Search - tctmd.com

Displaying 601 - 620 of 4004

Sort: Relevancy | Date

News Conference News TCT 2020

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Caitlin E. Cox

October 15, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

TCT 625: Stent Positioning Device Usage During PCI of Left Main Bifurcation

Presenter: Dmitrii Monosov

October 14, 2020

Presentation TCT 2020

TCT 602: Bewildering Pseudoaneurysm: An Odyssey of Cover Stenting

Presenter: ROOPESH SINGHAL

October 14, 2020

Presentation TCT 2020

TCT 561: Precise Stent Positioning in Ostial Lesion With New SPAS Device

Presenter: Artem Komkov

October 14, 2020

Presentation TCT 2020

TCT 529: 12-y/o Female Patient Treated With a Second-Generation Tyrocore Sirolimus-Eluting Bioresorbable Scaffold in a Denovo Coronary Stenosis in the Donor Heart After Transplantation

Presenter: Matthias Lutz

October 14, 2020

Presentation TCT 2020

TCT 391: 10-Year Outcomes After Drug-Eluting Stent Placement in Women Versus Men

Presenter: Nicole Pristera

October 14, 2020

Presentation TCT 2020

TCT 389: Risk of Major Bleeding in the 10 Years after DES in an All-Comers Population

Presenter: Calvin Sheng

October 14, 2020

Presentation TCT 2020

TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR)

Presenter: Jason Nogic

October 14, 2020

Presentation TCT 2020

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

Presenter: Robert Yeh

October 14, 2020

Presentation TCT 2020

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

Presenter: Luca Testa

October 14, 2020

Presentation TCT 2020

TCT 370: A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease

Presenter: Brian Forrestal

October 14, 2020

Presentation TCT 2020

TCT 317: Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With Critical Limb Ischaemia: The CREDENCE BtK-1 Study

Presenter: Vijay Thakore

October 14, 2020

Presentation TCT 2020

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

Presenter: Wojciech Wanha

October 14, 2020

Presentation TCT 2020

TCT 278: Prevalence and Anatomical Factors Associated to Vascular Remodeling Following Bioresorbable Scaffold Implantation

Presenter: Tatsuhiro Fujimura

October 14, 2020

Presentation TCT 2020

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

Presenter: Sridhar Kasturi, MD

October 14, 2020

Presentation TCT 2020

TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes

Presenter: Matthias Lutz

October 14, 2020

Presentation TCT 2020

TCT 274: Adaptive Coronary Rotation in the Drug-Eluting Bioadaptor With Uncaging Segments Reduces Stress on the Coronary Artery

Presenter: Mayank Kansal

October 14, 2020

Presentation TCT 2020

TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study

Presenter: Lukasz Koltowski

October 14, 2020

Presentation TCT 2020

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

Presenter: Alexandre Abizaid

October 14, 2020

Advertisement

Shorter DAPT Succeeds in Xience-Treated Patients at High Bleeding Risk

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

TCT 625: Stent Positioning Device Usage During PCI of Left Main Bifurcation

TCT 602: Bewildering Pseudoaneurysm: An Odyssey of Cover Stenting

TCT 561: Precise Stent Positioning in Ostial Lesion With New SPAS Device

TCT 529: 12-y/o Female Patient Treated With a Second-Generation Tyrocore Sirolimus-Eluting Bioresorbable Scaffold in a Denovo Coronary Stenosis in the Donor Heart After Transplantation

TCT 391: 10-Year Outcomes After Drug-Eluting Stent Placement in Women Versus Men

TCT 389: Risk of Major Bleeding in the 10 Years after DES in an All-Comers Population

TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR)

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

TCT 370: A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease

TCT 317: Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With Critical Limb Ischaemia: The CREDENCE BtK-1 Study

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

TCT 278: Prevalence and Anatomical Factors Associated to Vascular Remodeling Following Bioresorbable Scaffold Implantation

TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry

TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes

TCT 274: Adaptive Coronary Rotation in the Drug-Eluting Bioadaptor With Uncaging Segments Reduces Stress on the Coronary Artery

TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content